DML ABlogics develops and commercialised high quality monoclonal antibodies directed against microbial, tumor, tissue specific antigens as well as secondary antibodies for immunofluorescence, cytofluorimetry and immunochemistry.
To develop and deliver microfluidic dispense solutions for our customers in Biomedical, Chemical Sensing, Optical and Electronics industries based on Engineering Arts ActivePipette technology. At the core of our systems is the ActivePipette product whic
Plexera® develops products for detection and quantification of molecular binding interactions such as protein-protein, antibody-antigen, protein-oligonucleotide, and other molecular binding interactions.
antibody-validation.com
Sciomics: Antibody meets microarray - Home